Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Lomustine with or without a second round of brain radiation for the reappearance of glioblastoma Recruiting

2023-505267-36-00 Glioblastoma 5 2024-03-15
Safety and feasibility of immuno-OCT Recruiting

2023-506395-27-00 Barrett's esophagus 9 2024-03-15
A Master rollover study to provide continued access to, and assess, long term safety of the study drugs. Recruiting

2023-506330-73-00 Advanced (unresectable or metastatic) human epidermal g 5 2024-03-13
Phase I/IIa multicentre study of infusion of autologous peripheral blood T lymphocytes expanded and genetically modified using Sleeping Beau… Recruiting

2024-514544-90-00 Relapsed or refractory B-cell lymphoma 9 2024-03-11
IMPROCAS - Improved Prediction of Ovarian Cancer Surgery Recruiting

2023-503398-39-00 Ovarian cancer 4 2024-03-01
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy In HER2-positive gastric or gastroesophageal cancer patie… Recruiting

2023-506662-31-00 Gastric or gastroesophageal cancer 4 2024-02-28
A Phase I Study of VVD-133214 Alone and in Combination in Participants with Advanced Solid Tumors Recruiting

2023-503170-20-01 Advanced solid tumors 1 2024-02-26
THE EFFECT OF ABIRATERONE ON THE METABOLISM OF OXYCODONE (ENABLE study) Recruiting

2023-505705-17-00 Males aged  18 years with prostate cancer treated with 6 2024-02-23
An international, multicenter, randomised, superiority phase III, open label, 2-arm study to investigate distant metastasis free survival wi… Recruiting

2022-501453-36-00 Breast cancer 5 2024-02-23
A study to test how BI 764532 is taken up by tumours in people with small-cell lung cancer or neuroendocrine cancer Recruiting

2022-501818-54-00 Small cell lung carcinoma (SCLC) 3 2024-02-22
Treatment for breast cancer patients with meninges invaded by tumor cells Recruiting

2022-502351-60-00 Patients having a HER2-amplified metastatic breast canc 4 2024-02-22
Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib… Recruiting

2023-503708-10-00 Locally advanced or metastatic breast cancer 5 2024-02-20
First in Human Study of TOS-358 in Adults with Soid Tumors Recruiting

2023-505346-26-01 9 main solid tumors – colorectal, cervical, endometrial 7 2024-02-19
Trial to Better Characterize the Status of HRD leading to a Benefit from Olaparib in Combination with Bevacizumab in Patients with Advanced … Recruiting

2024-517363-24-00 Advanced FIGO Stage III‐IV High Grade Serous or Endomet 4 2024-02-16
An Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced… Recruiting

2023-503865-48-00 Locally Advanced or Metastatic Non-Small Cell Lung Canc 4 2024-02-16
A phase 2 trial in stage II-IIIa urothelial cancer randomizing pre-operative nivolumab with or without relatlimab - TURANDORELA Recruiting

2023-507460-39-00 Adult patients with resectable muscle-invasive urotheli 10 2024-02-15
A Phase I trial to establish the safety and maximum tolerated dose of high-affinity autologous BCMA-targeting CAR-T cells in patients with r… Recruiting

2022-502831-20-00 Male and female adult patients with relapsed Multiple M 1 2024-02-15
Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Recruiting

2023-506604-18-00 Triple negative breast cancer 1 2024-02-14
ICG-fluorescence imaging for intraoperative breast cancer margins evaluation: a dose-timing study Recruiting

2023-504024-26-00 Patients with primary invasive early breast cancer (T1- 4 2024-02-09
A study in men with advanced prostate cancer to determine the safety and effects of a test drug (Lutetium (177Lu) rhPSMA 10.1 injection) Recruiting

2024-511537-35-00 Metastatic castration-resistant prostate cancer (mCRPC) 9 2024-02-09
Efficacy and safety of conventional neoadjuvant therapy versus total neoadjuvant therapy in older patients with locally advanced rectal canc… Recruiting

2023-506703-26-00 locally advanced rectal cancer 5 2024-02-07
A study to evaluate the effects and safety of INCA033989 in participants with myelofibrosis or essential thrombocythemia Recruiting

2022-502514-86-00 Myeloproliferative Neoplasms 1 2024-02-07
Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-vol… Recruiting

2023-506698-36-00 low-volume metastatic castration-sensitive prostate can 5 2024-02-02
[18F]AlF-PSMA-11 PET in advanced thyroid and head and neck carcinoma Recruiting

2022-503036-13-00 Head and neck squamous cell carcinoma, thyroid carcinom 4 2024-02-01